Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree

NCT05986383 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 820

Last updated 2023-08-14

No results posted yet for this study

Summary

Liver failure (PHLF) after hepatectomy is a relatively serious postoperative complication. Previous studies have shown that liver reserve function is related to PHLF. The "Chinese expert consensus decision tree for hepatectomy" implemented recommends different surgical methods according to the liver function of patients and the standardized residual functional liver volume ratio, so as to achieve accurate hepatectomy and prolong the survival of patients. In the retrospective study, it showed the safety and effectiveness of the decision tree under the condition of extended hepatectomy indications, but it lacked prospective research to evaluate. Therefore, this study intends to evaluate the safety and effectiveness of hepatectomy under the guidance of Chinese expert consensus decision tree through prospective research.

Conditions

  • Primary Liver Cancer
  • Metastatic Liver Cancer
  • Benign Liver Neoplasms
  • Hepatic Echinococcosis

Sponsors & Collaborators

  • West China Hospital

    collaborator OTHER
  • Second Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • The First Hospital of Jilin University

    collaborator OTHER
  • Meng Chao Hepatobiliary Hospital of Fujian Medical University

    collaborator OTHER
  • LanZhou University

    collaborator OTHER
  • Southwest Hospital, China

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Affiliated Hospital of Qinghai University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Shenzhen People's Hospital

    collaborator OTHER
  • Zhongshan Hospital Xiamen University

    collaborator OTHER
  • Beijing Tsinghua Chang Gung Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-03-31
Completion
2024-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05986383 on ClinicalTrials.gov